SBiS 2020 : A Decade of Building a Global Korean Vascular Network
쉐라톤 서울 팔래스 강남 호텔 다이너스티홀
08:30-08:50	Registration 사회: 박형섭 (서울의대)
08:50-08:55	Opening Address Ku Yong Jeong (Ewha Womans Univ.)
08:55-09:00	Course review Taeseung Lee (Seoul National Univ.)
Session 1. LIVE connection with USA (I)
09:00-10:30	Moderators: Taeseung Lee (Seoul National Univ.) Hyung Sub Park (Seoul National Univ.)
09:00-09:15	Recorded live case 1: Transcarotid Arterial Revascularization (TCAR) Jae S Cho (Case Western Reserve Univ., USA)
09:15-09:30	Recorded live case 2: In-Situ FEVAR for ruptured unstable TAAA Sukgu M Han (Univ. of Southern California, USA)
09:30-09:45	Vascular surgeon's role during the COVID-19 pandemic: experience in the heart of NY Daniel K. Han (Mount Sinai Univ., USA)
09:45-10:00	Perioperative thromboprophylaxis in COVID-19 patients Cheong Jun Lee (Northshore Univ., USA)
10:00-10:15	BMT vs CEA vs CAS in asymptomatic carotid disease patients Jae S Cho (Case Western Reserve Univ., USA)
10:15-10:30	Customized FEVAR/BEVAR vs PMEG
10:30-10:50	Coffee break
Session 2. LIVE connection with USA (II)
10:50-12:20	Moderators: Sangil Min (Seoul National Univ.)
10:50-11:05	Bridging covered stents during FEVAR/BEVAR: which is best and why?
11:05-11:20	Neoaortoiliac System (NAIS) Procedure for Infected Aortic Graft Treatment Jayer Chung (Baylor Univ., USA)
11:20-11:35	DCB/DES use in claudicants vs critical limb ischemia patients: should they differ? Cheong Jun Lee (Northshore Univ., USA)
11:35-11:50	Guideline-based role of surgery in PAD: Will the BASIL-2 and BEST-CLI trials be a game changer? Jayer Chung (Baylor Univ., USA)
11:50-12:20	1. Deviating from the endo track (back to open) Suk Won Song (Yonsei Univ.)
	2. Still in track with some minor bumps (endo favored) Sukgu M Han (Univ. of Southern California, USA)
	Debate: The current status of the endovascular drive in thoracoabdominal aorta pathology
Special Session. LUNCHEON (Sponsored by BD Bard)
12:30-13:30	Moderators: Jongwon Ha (Seoul National Univ.)
12:30-13:30	Recorded lecture: Optimize Venous Stenting Outcomes : 24 month Vernacular Trial Results & Lessons Learned from the Expert on Venous Stenting Paul Gagne (Norwalk Hospital)
Session 3. Deep venous intervention: In Depth
13:30-14:50	Moderators: In Mok Jung (Seoul National Univ.) Sang Woo Park (Konkuk Univ.)
13:30-13:40	Recorded live case 3: PMEG for TAAA
13:40-13:50	Limitations of the CAVENT, ATTRACT and CAVA trials: Is anticoagulation alone enough for acute DVT Young Sun Yoo (Chosun Univ.)
13:50-14:00	Advantages of pharmacomechanical thrombectomy for deep vein thrombosis Sang Woo Park (Konkuk Univ.)
14:00-14:10	Thrombotic vs nonthrombotic iliocaval obstruction: Management strategies for CVI intervention Hyung Sub Park (Seoul National Univ.)
14:10-14:20	Medical management after deep venous stenting Keun Myoung Park (IIncheon Vascular Surgery)
14:20-14:30	Can all chronically occluded IVC filters be removed? Tips and tricks Je Hwan Won (Ajou Univ.)
14:30-14:50	Panel discussion
14:50-15:10	Coffee break
Session 4. Drug-based technology in PAD: Issues and solutions
15:10-16:20	Moderators: Sang Joon Kim (Professor Emeritus, Seoul National Univ.) Hwan Jun Jae (Seoul National Univ.)
15:10-15:20	One year since the DCB issue: what's the current evidence Suh Min Kim (Chung-Ang Univ.)
15:20-15:30	Pharmacology and toxicity of Paclitaxel: what's the influence? Seung-Woon Rha (Korea Univ.)
15:30-15:40	Is the increase in patency of drug-based technology justifiable in terms of cost-effectiveness? Chang-Hwan Yoon (Seoul National Univ.)
15:40-15:50	Updates on drug-based technology for BTK intervention Jae Hwan Lee (Chungnam National Univ.)
15:50-16:00	Strategies to improve drug-delivery efficiency in the SFA: are we dealing aggressively enough with the calcium burden? Jang Yong Kim (Catholic Univ.)
16:00-16:20	Panel discussion
Session 5. The Aorta Essentials
16:20-18:00	Moderators: Yong-Pil Cho (Ulsan Univ.) Youngwook Kim (Sungkyunkwan Univ.)
16:20-16:30	Recorded live case 4: Late open conversion after EVAR
16:30-17:00	Debate: Lowering the diameter threshold of EVAR to less than 5.5 cm
	1. Yes, an overstreched spring never comes back Kwang Hun Lee (Yonsei Univ.)
	2. No, that is not evidence-based or cost-effective Sang Su Lee (Pusan National Univ.)
17:00-17:10	Updates in medical treatment of AAA: the same old guys or any new kids on the stage? Jin Mo Kang (Gachon Univ.)
17:10-17:20	Implications of the NICE guideline: should all elective AAAs be treated surgically?
17:20-17:30	Unveiling sac biology: Rapid sac growth phenomenon after EVAR compared to untreated natural AAA - What's the implication? Jin Hyun Joh (Kyung Hee Univ.)
17:30-17:40	Late ruptures of AAA after EVAR Seung Huh (Kyungpook National Univ.)
17:40-17:50	EVAR for ruptured AAA: ways to increase implementation. Sun Cheol Park (Catholic Univ.)
17:50-18:00	Panel discussion
18:00-00:00	Closing Remarks